High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects

April 12, 2020 updated by: Cerini Tamara

12 Week High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects: a Randomized Single-blinded Feasibility Study

The current guidelines for non-specific CLBP, recommend a conservative approach with exercise therapy, as first line treatment. Endurance and resistance training are two examples of recommended exercise therapies. However, it appears that none is recommended as superior over the other.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The lack of studies using HIIT in CLBP subjects, is the reason why it is needed to conduct an investigation about its effects.

However, firstly it is needed to assess the feasibility and safety of the HIIT protocol, to integrate it in the daily practise and future research.

In a single-center, single-blinded randomized feasiblity study, the investigators aim to prove the feasibility and safety of a 12 week HIIT programm.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zürich, Switzerland, 8008
        • Schulthess Klinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

27 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Oswestry disability index (ODI) Score ≥ 14%
  • Low back pain for at least 3 months.
  • Declared suitable by their physician or hospital consultant to start an exercise programme and to perform a graded exercise testing to determine the heart rate peak.
  • Good understanding of German or English, written and spoken.
  • Age between 29 - 69
  • No or stopped physical therapy.

Exclusion Criteria:

  • Pre-existing unstable heart disease or suspected angina pectoris, cardiac dysrhythmias, heart failure, aneurysm or aortic stenosis.
  • Known pregnancy.
  • Previous low back spinal surgery in the last 2 years.
  • Tumour, spinal stenosis, spinal fractures or radiculopathy.
  • Comorbid health conditions like diabetes mellitus, rheumatoid arthritis or other systemic inflammatory diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MICT
  • 5 min. warm up
  • 20 min. continuous cycling: HRR btw. 40% - 59%
  • 5 min. cool down
Other Names:
  • moderate intensiv continuous training
Active Comparator: HIIT
  • 5 min. warm up
  • 10 × 60 seconds burst
  • 60 seconds recovery after each burst
  • Burst phase: HRR >90%
  • Recovery phase: HRR btw. 30-39%
  • 5 min. cool down
Other Names:
  • high intensity interval training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: 13 weeks
Difference in training adherence rate between HIIT and MICT. The adherence rate will be calculated in the amount of days a patient trained versus the total days they were scheduled to train.
13 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enjoyability
Time Frame: 13 week
Likert scale from -3 to +3. -3 = I hate it, 0 = Neutral, +3 = I enjoy it.
13 week
Willingness to continue the training
Time Frame: 13 weeks
Likert scale from -3 to +3. -3 = Very low, 0 = Neutral, +3 = Very high.
13 weeks
Number of Adverse Events & Dropout rate
Time Frame: 13 weeks
Dropout rate and adverse events connected with the training
13 weeks
Recruited rate
Time Frame: 3 months
Screened patients in relation with the number of recruited patients
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry disability index
Time Frame: 13 weeks
The Oswestry low back pain disability questionnaire examines the perceived level of disability in the everyday activities of daily living. 0% to 20% = Minimal disability; 21% to 40% = Moderate disability; 41% to 60% = Severe disability; 61% to 80% = crippled; 81% to 100%.
13 weeks
Numeric Pain Rate Scale
Time Frame: 13 weeks
Pain score from 0 to 10. 0 = No pain, 5 = Moderate pain, 10 = Worst possible pain.
13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2019

Primary Completion (Actual)

March 13, 2020

Study Completion (Actual)

March 13, 2020

Study Registration Dates

First Submitted

August 10, 2019

First Submitted That Met QC Criteria

August 10, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

April 14, 2020

Last Update Submitted That Met QC Criteria

April 12, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HIITvsMICT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on MICT

3
Subscribe